Logo image of ELES.MI

ELES SEMICONDUCTOR EQUIPMENT (ELES.MI) Stock Fundamental Analysis

BIT:ELES - Euronext Milan - IT0005373417 - Common Stock - Currency: EUR

2.18  -0.01 (-0.46%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ELES. ELES was compared to 56 industry peers in the Semiconductors & Semiconductor Equipment industry. ELES has only an average score on both its financial health and profitability. ELES is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year ELES was profitable.
ELES had a positive operating cash flow in the past year.
In the past 5 years ELES has always been profitable.
Of the past 5 years ELES 4 years had a positive operating cash flow.
ELES.MI Yearly Net Income VS EBIT VS OCF VS FCFELES.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

1.2 Ratios

ELES has a Return On Assets of 2.24%. This is amonst the worse of the industry: ELES underperforms 80.36% of its industry peers.
ELES has a Return On Equity of 4.47%. This is in the lower half of the industry: ELES underperforms 75.00% of its industry peers.
The Return On Invested Capital of ELES (6.98%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for ELES is significantly below the industry average of 15.42%.
The 3 year average ROIC (4.69%) for ELES is below the current ROIC(6.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROIC 6.98%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ELES.MI Yearly ROA, ROE, ROICELES.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ELES's Profit Margin of 3.48% is on the low side compared to the rest of the industry. ELES is outperformed by 80.36% of its industry peers.
In the last couple of years the Profit Margin of ELES has declined.
With a Operating Margin value of 12.08%, ELES is not doing good in the industry: 60.71% of the companies in the same industry are doing better.
ELES's Operating Margin has improved in the last couple of years.
ELES has a Gross Margin of 51.40%. This is in the better half of the industry: ELES outperforms 67.86% of its industry peers.
In the last couple of years the Gross Margin of ELES has grown nicely.
Industry RankSector Rank
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
ELES.MI Yearly Profit, Operating, Gross MarginsELES.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELES is destroying value.
ELES has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ELES has been increased compared to 5 years ago.
ELES has a better debt/assets ratio than last year.
ELES.MI Yearly Shares OutstandingELES.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ELES.MI Yearly Total Debt VS Total AssetsELES.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ELES has an Altman-Z score of 2.40. This is not the best score and indicates that ELES is in the grey zone with still only limited risk for bankruptcy at the moment.
ELES has a Altman-Z score of 2.40. This is in the lower half of the industry: ELES underperforms 71.43% of its industry peers.
The Debt to FCF ratio of ELES is 2.75, which is a good value as it means it would take ELES, 2.75 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ELES (2.75) is comparable to the rest of the industry.
ELES has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.34, ELES is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Altman-Z 2.4
ROIC/WACC0.68
WACC10.24%
ELES.MI Yearly LT Debt VS Equity VS FCFELES.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

2.3 Liquidity

A Current Ratio of 2.33 indicates that ELES has no problem at all paying its short term obligations.
ELES has a Current ratio (2.33) which is comparable to the rest of the industry.
ELES has a Quick Ratio of 1.79. This is a normal value and indicates that ELES is financially healthy and should not expect problems in meeting its short term obligations.
ELES has a better Quick ratio (1.79) than 60.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 1.79
ELES.MI Yearly Current Assets VS Current LiabilitesELES.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.37% over the past year.
The Earnings Per Share has been growing slightly by 0.68% on average over the past years.
The Revenue has grown by 8.92% in the past year. This is quite good.
ELES shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.31% yearly.
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%

3.2 Future

Based on estimates for the next years, ELES will show a very strong growth in Earnings Per Share. The EPS will grow by 44.29% on average per year.
Based on estimates for the next years, ELES will show a quite strong growth in Revenue. The Revenue will grow by 12.52% on average per year.
EPS Next Y66.67%
EPS Next 2Y52.75%
EPS Next 3Y41.5%
EPS Next 5Y44.29%
Revenue Next Year14.17%
Revenue Next 2Y12.55%
Revenue Next 3Y10.52%
Revenue Next 5Y12.52%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ELES.MI Yearly Revenue VS EstimatesELES.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M 50M
ELES.MI Yearly EPS VS EstimatesELES.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.05 0.1 0.15 0.2 0.25

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.25, the valuation of ELES can be described as expensive.
ELES's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.04, ELES is valued at the same level.
ELES is valuated rather expensively with a Price/Forward Earnings ratio of 21.37.
ELES's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 37.64. ELES is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 27.25
Fwd PE 21.37
ELES.MI Price Earnings VS Forward Price EarningsELES.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ELES's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ELES is cheaper than 91.07% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than ELES, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.34
EV/EBITDA 5.67
ELES.MI Per share dataELES.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

ELES's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ELES's earnings are expected to grow with 41.50% in the coming years.
PEG (NY)0.41
PEG (5Y)39.9
EPS Next 2Y52.75%
EPS Next 3Y41.5%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ELES!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELES SEMICONDUCTOR EQUIPMENT

BIT:ELES (7/21/2025, 7:00:00 PM)

2.18

-0.01 (-0.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.74%
Inst Owner ChangeN/A
Ins Owners31.74%
Ins Owner ChangeN/A
Market Cap37.47M
Analysts82.86
Price Target3.25 (49.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 27.25
Fwd PE 21.37
P/S 1.05
P/FCF 6.34
P/OCF 5.95
P/B 1.35
P/tB 2.08
EV/EBITDA 5.67
EPS(TTM)0.08
EY3.67%
EPS(NY)0.1
Fwd EY4.68%
FCF(TTM)0.34
FCFY15.77%
OCF(TTM)0.37
OCFY16.8%
SpS2.08
BVpS1.62
TBVpS1.05
PEG (NY)0.41
PEG (5Y)39.9
Profitability
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROCE 10.95%
ROIC 6.98%
ROICexc 9.24%
ROICexgc 13.76%
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
FCFM 16.55%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ROICexc(3y)6.24%
ROICexc(5y)5.97%
ROICexgc(3y)9.41%
ROICexgc(5y)8.84%
ROCE(3y)7.35%
ROCE(5y)6.52%
ROICexcg growth 3Y38.04%
ROICexcg growth 5Y10.61%
ROICexc growth 3Y34.42%
ROICexc growth 5Y9.58%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
F-Score9
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Debt/EBITDA 1.27
Cap/Depr 12.67%
Cap/Sales 1.08%
Interest Coverage 250
Cash Conversion 85.52%
Profit Quality 475.3%
Current Ratio 2.33
Quick Ratio 1.79
Altman-Z 2.4
F-Score9
WACC10.24%
ROIC/WACC0.68
Cap/Depr(3y)32.99%
Cap/Depr(5y)27.08%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
EPS Next Y66.67%
EPS Next 2Y52.75%
EPS Next 3Y41.5%
EPS Next 5Y44.29%
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%
Revenue Next Year14.17%
Revenue Next 2Y12.55%
Revenue Next 3Y10.52%
Revenue Next 5Y12.52%
EBIT growth 1Y38.54%
EBIT growth 3Y59.16%
EBIT growth 5Y29.31%
EBIT Next Year200%
EBIT Next 3Y58.14%
EBIT Next 5Y50.77%
FCF growth 1Y269.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.26%
OCF growth 3YN/A
OCF growth 5YN/A